6533b871fe1ef96bd12d1c7d
RESEARCH PRODUCT
Incidence and Risk Factors for Tractional Macular Detachment after Anti-Vascular Endothelial Growth Factor Agent Pretreatment before Vitrectomy for Complicated Proliferative Diabetic Retinopathy
Matteo FallicoVincenza BonfiglioTeresio AvitabileMichele ReibaldiFrancesco BosciaAndrea RussoAntonio LongoKatarzyna NowomiejskaRobert RejdakSalvatore CillinoMario Damiano ToroMario Damiano ToroClaudio Furinosubject
medicine.medical_specialtyYounger agegenetic structuresmedicine.medical_treatmentvitrectomyVitrectomytractional macular detachmentArticle03 medical and health sciences0302 clinical medicineOphthalmologymedicine030212 general & internal medicineanti-VEGF; proliferative diabetic retinopathy; tractional macular detachment; vitrectomyAnti vegfbusiness.industryPrimary vitrectomyIncidence (epidemiology)General MedicineDiabetic retinopathymedicine.diseaseeye diseasesMacular detachmentanti-VEGFVitreous hemorrhage030221 ophthalmology & optometrysense organsbusinessproliferative diabetic retinopathydescription
The study&rsquo
year | journal | country | edition | language |
---|---|---|---|---|
2019-11-13 | Journal of Clinical Medicine |